- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
– Financing led by Nextech Invest with participation from Cormorant Asset Management, BVF Partners, L.P., Janus Henderson Investors, and Logos, along with existing investors Alta Partners, RA Capital, Boxer Capital of Tavistock Group, and Canaan – Hiroomi Tada, MD, PhD named Chief Medical Officer, Piyush Patel, PhD named Chief Development Officer, and Robert L. Hudkins, […]
– Round co-led by Alta Partners, RA Capital, Boxer Capital of Tavistock Group, and Canaan, representing a group of seasoned early-stage and crossover investors – Experienced team well positioned to tackle acquired resistance, a devastating reality for patients initially responding to targeted therapies CARLSBAD, Calif., Jan. 10, 2020  — Today Tyra Biosciences announced a Series […]